Acebrophylline (Sustained Release), Desloratadine & Montelukast Sodium Tablets

Fexmo-AD Tablets are a triple-action combination designed to provide comprehensive management of respiratory disorders such as asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD).

Acebrophylline (SR)

• Bronchodilator that relaxes smooth muscles of the airways

• Reduces mucus viscosity, improving expectoration and airflow

• Sustained-release formulation ensures prolonged therapeutic effect

Desloratadine

• Selectively inhibits H1 histamine receptors, reducing allergic reactions

• Alleviates sneezing, itching, runny nose, and watery eyes

• Non-sedating, suitable for daytime use

Montelukast Sodium

• Blocks cysteinyl leukotriene receptors

• Prevents airway inflammation, bronchoconstriction, and mucus secretion

• Reduces asthma attacks and allergy-related airway obstruction